Ireland
--:--IST
Latest
Clinical Trials in France / NCT07625033
Starting soon Observational

Risk Factors of Atrial Fibrillation After Cardiac Surgery

NCT07625033 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-07-01
Last updated
2026-06-25

Condition(s) studied

Cardiac SurgeryPeri Operative MedicineThoracic SurgeryCardiopulmonary BypassCoronary Artery BypassHeart Valve Prosthesis ImplantationAortic Valve ReplacementPerioperative MedicinePreoperative CareIntraoperative CarePostoperative CareEnhanced Recovery After SurgeryAnesthesiaCardiac AnesthesiaIntensive Care Unit

Study summary

Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * age \>18 * having undergone a scheduled cardiac surgery in the study center * having agreed to the reuse of their hospital care data Exclusion Criteria: * Atrial fibrillation at the admission in hospital.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHR Metz-Thionville Hopital de Mercy Metz France

More Centre Hospitalier Régional Metz-Thionville trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07625033 on ClinicalTrials.gov ↗ ← All trials in France